Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

A TP63 mutation causes prominent alopecia with mild ectodermal dysplasia.

Duchatelet S, Russo C, Osterburg C, Mallet S, Bole-Feysot C, Nitschké P, Richard MA, Dötsch V, Missero C, Nassif A, Hovnanian A.

J Invest Dermatol. 2019 Nov 1. pii: S0022-202X(19)33376-7. doi: 10.1016/j.jid.2019.06.154. [Epub ahead of print] No abstract available.

PMID:
31682841
2.

A previously unreported frameshift ATP2C1 mutation in a generalized Hailey-Hailey disease.

Leducq S, Duchatelet S, Zaragoza J, Ventéjou S, de Muret A, Eymieux S, Blanchard E, Machet L, Hovnanian A, Kervarrec T.

J Eur Acad Dermatol Venereol. 2019 Oct 29. doi: 10.1111/jdv.16038. [Epub ahead of print]

PMID:
31660662
3.

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.

Gaucher S, Lwin SM, Titeux M, Abdul-Wahab A, Pironon N, Izmiryan A, Miskinyte S, Ganier C, Duchatelet S, Mellerio JE, Bourrat E, McGrath JA, Hovnanian A.

Br J Dermatol. 2019 Sep 26. doi: 10.1111/bjd.18559. [Epub ahead of print] No abstract available.

PMID:
31557321
4.

Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.

Walker AL, Denis A, Bingham RP, Bouillot A, Edgar EV, Ferrie A, Holmes DS, Laroze A, Liddle J, Fouchet MH, Moquette A, Nassau P, Pearce AC, Polyakova O, Smith KJ, Thomas P, Thorpe JH, Trottet L, Wang Y, Hovnanian A.

Bioorg Med Chem Lett. 2019 Oct 15;29(20):126675. doi: 10.1016/j.bmcl.2019.126675. Epub 2019 Sep 7.

PMID:
31521475
5.

Remission of chronic acne fulminans and severe hidradenitis suppurativa with targeted antibiotherapy.

Duchatelet S, Join-Lambert O, Delage M, Miskinyte S, Guet-Revillet H, Lam T, Coignard-Biehler H, Ungeheuer MN, Chatenoud L, Lortholary O, Nassif X, Hovnanian A, Nassif AS.

JAAD Case Rep. 2019 Jun 8;5(6):525-528. doi: 10.1016/j.jdcr.2019.04.001. eCollection 2019 Jun. No abstract available.

6.

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.

Lwin SM, Syed F, Di WL, Kadiyirire T, Liu L, Guy A, Petrova A, Abdul-Wahab A, Reid F, Phillips R, Elstad M, Georgiadis C, Aristodemou S, Lovell PA, McMillan JR, Mee J, Miskinyte S, Titeux M, Ozoemena L, Pramanik R, Serrano S, Rowles R, Maurin C, Orrin E, Martinez-Queipo M, Rashidghamat E, Tziotzios C, Onoufriadis A, Chen M, Chan L, Farzaneh F, Del Rio M, Tolar J, Bauer JW, Larcher F, Antoniou MN, Hovnanian A, Thrasher AJ, Mellerio JE, Qasim W, McGrath JA.

JCI Insight. 2019 Jun 6;4(11). pii: 126243. doi: 10.1172/jci.insight.126243. eCollection 2019 Jun 6.

7.

Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds.

Sbidian E, Madrange M, Viguier M, Salmona M, Duchatelet S, Hovnanian A, Smahi A, Le Goff J, Bachelez H.

Br J Dermatol. 2019 May 31. doi: 10.1111/bjd.18203. [Epub ahead of print] No abstract available.

PMID:
31150103
8.

Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome.

Thorpe JH, Edgar EV, Smith KJ, Lewell XQ, Rella M, White GV, Polyakova O, Nassau P, Walker AL, Holmes DS, Pearce AC, Wang Y, Liddle J, Hovnanian A.

Acta Crystallogr F Struct Biol Commun. 2019 May 1;75(Pt 5):385-391. doi: 10.1107/S2053230X19003169. Epub 2019 Apr 26.

PMID:
31045568
9.

Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome.

Walker AL, Bingham RP, Edgar EV, Ferrie A, Holmes DS, Liddle J, Polyakova O, Rella M, Smith KJ, Thorpe JH, Wang Y, White GV, Young RJ, Hovnanian A.

Bioorg Med Chem Lett. 2019 Jun 15;29(12):1454-1458. doi: 10.1016/j.bmcl.2019.04.022. Epub 2019 Apr 12.

PMID:
31005442
10.

Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.

Atanasova VS, Pourreyron C, Farshchian M, Lawler M, Brown CA 4th, Watt SA, Wright S, Warkala M, Guttmann-Gruber C, Hofbauer JP, Fuentes I, Prisco M, Rashidghamat E, Has C, Salas-Alanis JC, Palisson F, Hovnanian A, McGrath JA, Mellerio JE, Bauer JW, South AP.

Clin Cancer Res. 2019 Jun 1;25(11):3384-3391. doi: 10.1158/1078-0432.CCR-18-2661. Epub 2019 Mar 7.

PMID:
30846478
11.

Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

Ebens CL, McGrath JA, Tamai K, Hovnanian A, Wagner JE, Riddle MJ, Keene DR, DeFor TE, Tryon R, Chen M, Woodley DT, Hook K, Tolar J.

Br J Dermatol. 2019 Mar 6. doi: 10.1111/bjd.17858. [Epub ahead of print]

PMID:
30843184
12.

Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.

White GV, Edgar EV, Holmes DS, Lewell XQ, Liddle J, Polyakova O, Smith KJ, Thorpe JH, Walker AL, Wang Y, Young RJ, Hovnanian A.

Bioorg Med Chem Lett. 2019 Mar 15;29(6):821-825. doi: 10.1016/j.bmcl.2019.01.020. Epub 2019 Jan 22.

PMID:
30691925
13.

Epidermolysis bullosa simplex-generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype-phenotype correlation and in silico modeling analysis.

Lalor L, Titeux M, Palisson F, Fuentes I, Yubero MJ, Tasanen K, Huilaja L, Has C, Tadini G, Haggstrom AN, Hovnanian A, Lucky AW.

Pediatr Dermatol. 2019 Jan;36(1):132-138. doi: 10.1111/pde.13722. Epub 2018 Dec 4.

PMID:
30515866
14.

Correction to: Antisense-Mediated Splice Modulation to Reframe Transcripts.

Titeux M, Turczynski S, Pironon N, Hovnanian A.

Methods Mol Biol. 2018;1828:E1. doi: 10.1007/978-1-4939-8651-4_37.

PMID:
30488375
15.

Mutations in PERP Cause Dominant and Recessive Keratoderma.

Duchatelet S, Boyden LM, Ishida-Yamamoto A, Zhou J, Guibbal L, Hu R, Lim YH, Bole-Feysot C, Nitschké P, Santos-Simarro F, de Lucas R, Milstone LM, Gildenstern V, Helfrich YR, Attardi LD, Lifton RP, Choate KA, Hovnanian A.

J Invest Dermatol. 2019 Feb;139(2):380-390. doi: 10.1016/j.jid.2018.08.026. Epub 2018 Oct 12.

PMID:
30321533
16.

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.

Izmiryan A, Ganier C, Bovolenta M, Schmitt A, Mavilio F, Hovnanian A.

Mol Ther Nucleic Acids. 2018 Sep 7;12:554-567. doi: 10.1016/j.omtn.2018.06.008. Epub 2018 Jun 26.

17.

Antisense-Mediated Splice Modulation to Reframe Transcripts.

Titeux M, Turczynski S, Pironon N, Hovnanian A.

Methods Mol Biol. 2018;1828:531-552. doi: 10.1007/978-1-4939-8651-4_35. Erratum in: Methods Mol Biol. 2018;1828:E1.

PMID:
30171566
18.

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Cho RJ, Alexandrov LB, den Breems NY, Atanasova VS, Farshchian M, Purdom E, Nguyen TN, Coarfa C, Rajapakshe K, Prisco M, Sahu J, Tassone P, Greenawalt EJ, Collisson EA, Wu W, Yao H, Su X, Guttmann-Gruber C, Hofbauer JP, Hashmi R, Fuentes I, Benz SC, Golovato J, Ehli EA, Davis CM, Davies GE, Covington KR, Murrell DF, Salas-Alanis JC, Palisson F, Bruckner AL, Robinson W, Has C, Bruckner-Tuderman L, Titeux M, Jonkman MF, Rashidghamat E, Lwin SM, Mellerio JE, McGrath JA, Bauer JW, Hovnanian A, Tsai KY, South AP.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaas9668. doi: 10.1126/scitranslmed.aas9668.

PMID:
30135250
19.

Epidermolysis Bullosa Simplex with KLHL24 Mutations Is Associated with Dilated Cardiomyopathy.

Schwieger-Briel A, Fuentes I, Castiglia D, Barbato A, Greutmann M, Leppert J, Duchatelet S, Hovnanian A, Burattini S, Yubero MJ, Ibañez-Arenas R, Rebolledo-Jaramillo B, Gräni C, Ott H, Theiler M, Weibel L, Paller AS, Zambruno G, Fischer J, Palisson F, Has C.

J Invest Dermatol. 2019 Jan;139(1):244-249. doi: 10.1016/j.jid.2018.07.022. Epub 2018 Aug 16. No abstract available.

PMID:
30120936
20.

A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

Béziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, Pellier I, Zoghi S, Baris S, Keles S, Gray P, Du N, Wang Y, Zerbib Y, Lévy R, Leclercq T, About F, Lim AI, Rao G, Payne K, Pelham SJ, Avery DT, Deenick EK, Pillay B, Chou J, Guery R, Belkadi A, Guérin A, Migaud M, Rattina V, Ailal F, Benhsaien I, Bouaziz M, Habib T, Chaussabel D, Marr N, El-Benna J, Grimbacher B, Wargon O, Bustamante J, Boisson B, Müller-Fleckenstein I, Fleckenstein B, Chandesris MO, Titeux M, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Meyts I, Di Santo JP, Hovnanian A, Somer A, Ozen A, Rezaei N, Chatila TA, Abel L, Leonard WJ, Tangye SG, Puel A, Casanova JL.

Sci Immunol. 2018 Jun 15;3(24). pii: eaat4956. doi: 10.1126/sciimmunol.aat4956.

21.

Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model.

Ganier C, Titeux M, Gaucher S, Peltzer J, Le Lorc'h M, Lataillade JJ, Ishida-Yamamoto A, Hovnanian A.

J Invest Dermatol. 2018 Nov;138(11):2483-2486. doi: 10.1016/j.jid.2018.04.028. Epub 2018 Jul 12. No abstract available.

22.

A new nonsense mutation in the POGLUT1 gene in two sisters with Dowling-Degos disease.

Duchatelet S, Clerc H, Machet L, Gaboriaud P, Miskinyte S, Kervarrec T, Hovnanian A.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):e440-e442. doi: 10.1111/jdv.14958. Epub 2018 Jul 31. No abstract available.

PMID:
29569780
23.

Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.

Wally V, Hovnanian A, Ly J, Buckova H, Brunner V, Lettner T, Ablinger M, Felder TK, Hofbauer P, Wolkersdorfer M, Lagler FB, Hitzl W, Laimer M, Kitzmüller S, Diem A, Bauer JW.

J Am Acad Dermatol. 2018 May;78(5):892-901.e7. doi: 10.1016/j.jaad.2018.01.019. Epub 2018 Feb 2.

24.

Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread.

Hoffmann HH, Schneider WM, Blomen VA, Scull MA, Hovnanian A, Brummelkamp TR, Rice CM.

Cell Host Microbe. 2017 Oct 11;22(4):460-470.e5. doi: 10.1016/j.chom.2017.09.002.

25.

Estimation of Stroke Volume and Stroke Volume Changes by Electrical Impedance Tomography.

da Silva Ramos FJ, Hovnanian A, Souza R, Azevedo LCP, Amato MBP, Costa ELV.

Anesth Analg. 2018 Jan;126(1):102-110. doi: 10.1213/ANE.0000000000002271.

PMID:
28742775
26.

PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity.

Sonbol H, Duchatelet S, Miskinyte S, Bonsang B, Hovnanian A, Misery L.

Br J Dermatol. 2018 Jan;178(1):e17-e18. doi: 10.1111/bjd.15740. Epub 2017 Dec 6. No abstract available.

PMID:
28626985
27.

TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand.

Pattarini L, Trichot C, Bogiatzi S, Grandclaudon M, Meller S, Keuylian Z, Durand M, Volpe E, Madonna S, Cavani A, Chiricozzi A, Romanelli M, Hori T, Hovnanian A, Homey B, Soumelis V.

J Exp Med. 2017 May 1;214(5):1529-1546. doi: 10.1084/jem.20150402. Epub 2017 Apr 20.

28.

The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.

Titeux M, Izmiryan A, Hovnanian A.

J Invest Dermatol. 2017 May;137(5):e123-e129. doi: 10.1016/j.jid.2016.08.038. Review.

29.

The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study.

Guet-Revillet H, Jais JP, Ungeheuer MN, Coignard-Biehler H, Duchatelet S, Delage M, Lam T, Hovnanian A, Lortholary O, Nassif X, Nassif A, Join-Lambert O.

Clin Infect Dis. 2017 Jul 15;65(2):282-291. doi: 10.1093/cid/cix285.

PMID:
28379372
30.

Epidermolytic Ichthyosis Sine Epidermolysis.

Eskin-Schwartz M, Drozhdina M, Sarig O, Gat A, Jackman T, Isakov O, Shomron N, Samuelov L, Malchin N, Peled A, Vodo D, Hovnanian A, Ruzicka T, Koshkin S, Harmon RM, Koetsier JL, Green KJ, Paller AS, Sprecher E.

Am J Dermatopathol. 2017 Jun;39(6):440-444. doi: 10.1097/DAD.0000000000000674.

31.

Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.

Wang Y, Ma CS, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, Payne K, Crestani E, Roncagalli R, Belkadi A, Kerner G, Lorenzo L, Deswarte C, Chrabieh M, Patin E, Vincent QB, Müller-Fleckenstein I, Fleckenstein B, Ailal F, Quintana-Murci L, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Puel A, Bustamante J, Boisson-Dupuis S, Malissen M, Malissen B, Abel L, Hovnanian A, Notarangelo LD, Jouanguy E, Tangye SG, Béziat V, Casanova JL.

J Exp Med. 2016 Oct 17;213(11):2413-2435. Epub 2016 Sep 19.

32.

Mechanistic insight from murine models of Netherton syndrome.

Keuylian Z, Hovnanian A.

Biol Chem. 2016 Dec 1;397(12):1223-1228. doi: 10.1515/hsz-2016-0203. Review.

PMID:
27710911
33.

Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.

de Veer SJ, Furio L, Swedberg JE, Munro CA, Brattsand M, Clements JA, Hovnanian A, Harris JM.

J Invest Dermatol. 2017 Feb;137(2):430-439. doi: 10.1016/j.jid.2016.09.017. Epub 2016 Sep 30.

34.

Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.

Turczynski S, Titeux M, Tonasso L, Décha A, Ishida-Yamamoto A, Hovnanian A.

J Invest Dermatol. 2016 Dec;136(12):2387-2395. doi: 10.1016/j.jid.2016.07.029. Epub 2016 Aug 3.

35.

Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.

Jacków J, Titeux M, Portier S, Charbonnier S, Ganier C, Gaucher S, Hovnanian A.

J Invest Dermatol. 2016 Jul;136(7):1346-1354. doi: 10.1016/j.jid.2016.02.811. Epub 2016 Mar 16.

36.

Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).

Seta V, Aucouturier F, Bonnefoy J, Le Roux-Villet C, Pendaries V, Alexandre M, Grootenboer-Mignot S, Heller M, Lièvre N, Laroche L, Caux F, Titeux M, Hovnanian A, Prost-Squarcioni C.

J Am Acad Dermatol. 2016 Jun;74(6):1166-72. doi: 10.1016/j.jaad.2016.01.005. Epub 2016 Mar 3.

PMID:
26947449
37.

Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa.

Izmiryan A, Danos O, Hovnanian A.

J Invest Dermatol. 2016 Apr;136(4):872-875. doi: 10.1016/j.jid.2015.11.028. Epub 2016 Feb 17. No abstract available.

38.

Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and Finnish SPINK5 Founder Mutation.

Hannula-Jouppi K, Laasanen SL, Ilander M, Furio L, Tuomiranta M, Marttila R, Jeskanen L, Häyry V, Kanerva M, Kivirikko S, Tuomi ML, Heikkilä H, Mustjoki S, Hovnanian A, Ranki A.

JAMA Dermatol. 2016 Apr;152(4):435-42. doi: 10.1001/jamadermatol.2015.5827.

PMID:
26865388
39.

Skin Biopsy in Netherton Syndrome: A Histological Review of a Large Series and New Findings.

Leclerc-Mercier S, Bodemer C, Furio L, Hadj-Rabia S, de Peufeilhoux L, Weibel L, Bursztejn AC, Bourrat E, Ortonne N, Molina TJ, Hovnanian A, Fraitag S.

Am J Dermatopathol. 2016 Feb;38(2):83-91. doi: 10.1097/DAD.0000000000000425.

40.

Marked intrafamilial phenotypic heterogeneity in dystrophic epidermolysis bullosa caused by inheritance of a mild dominant glycine substitution and a novel deep intronic recessive COL7A1 mutation.

Turczynski S, Titeux M, Pironon N, Cohn HI, Murrell DF, Hovnanian A.

Br J Dermatol. 2016 May;174(5):1122-5. doi: 10.1111/bjd.14312. Epub 2016 Feb 3. No abstract available.

PMID:
26595603
41.

Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.

Join-Lambert O, Coignard-Biehler H, Jais JP, Delage M, Guet-Revillet H, Poirée S, Duchatelet S, Jullien V, Hovnanian A, Lortholary O, Nassif X, Nassif A.

J Antimicrob Chemother. 2016 Feb;71(2):513-20. doi: 10.1093/jac/dkv361. Epub 2015 Nov 12.

PMID:
26565016
42.

Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.

Join-Lambert O, Duchatelet S, Delage M, Miskinyte S, Coignard H, Lemarchand N, Alemy-Carreau M, Lortholary O, Nassif X, Hovnanian A, Nassif A.

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S66-9. doi: 10.1016/j.jaad.2015.07.040.

PMID:
26470620
43.

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.

Furio L, Pampalakis G, Michael IP, Nagy A, Sotiropoulou G, Hovnanian A.

PLoS Genet. 2015 Sep 21;11(9):e1005389. doi: 10.1371/journal.pgen.1005389. eCollection 2015 Sep.

44.

Deciphering the microbiology of hidradenitis suppurativa: a step forward towards understanding an enigmatic inflammatory skin disease.

Delage M, Guet-Revillet H, Duchatelet S, Hovnanian A, Nassif X, Nassif A, Join-Lambert O.

Exp Dermatol. 2015 Oct;24(10):736-7. doi: 10.1111/exd.12830. No abstract available.

PMID:
26269245
45.

Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.

Duchatelet S, Hovnanian A.

J Invest Dermatol. 2015 Jun;135(6):1475-1478. doi: 10.1038/jid.2014.535.

46.

Olmsted syndrome: clinical, molecular and therapeutic aspects.

Duchatelet S, Hovnanian A.

Orphanet J Rare Dis. 2015 Mar 17;10:33. doi: 10.1186/s13023-015-0246-5. Review.

47.

First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome.

Duchatelet S, Miskinyte S, Join-Lambert O, Ungeheuer MN, Francès C, Nassif A, Hovnanian A.

Br J Dermatol. 2015 Aug;173(2):610-2. doi: 10.1111/bjd.13668. Epub 2015 Jun 11. No abstract available.

PMID:
25601011
48.

Toward the first class of suicide inhibitors of kallikreins involved in skin diseases.

Tan X, Soualmia F, Furio L, Renard JF, Kempen I, Qin L, Pagano M, Pirotte B, El Amri C, Hovnanian A, Reboud-Ravaux M.

J Med Chem. 2015 Jan 22;58(2):598-612. doi: 10.1021/jm500988d. Epub 2014 Dec 22.

PMID:
25489658
49.

Bacterial pathogens associated with hidradenitis suppurativa, France.

Guet-Revillet H, Coignard-Biehler H, Jais JP, Quesne G, Frapy E, Poirée S, Le Guern AS, Le Flèche-Matéos A, Hovnanian A, Consigny PH, Lortholary O, Nassif X, Nassif A, Join-Lambert O.

Emerg Infect Dis. 2014 Dec;20(12):1990-8. doi: 10.3201/eid2012.140064.

50.

HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.

Hennig K, Raasch L, Kolbe C, Weidner S, Leisegang M, Uckert W, Titeux M, Hovnanian A, Kuehlcke K, Loew R.

Hum Gene Ther Clin Dev. 2014 Dec;25(4):218-28. doi: 10.1089/humc.2014.083.

PMID:
25381930

Supplemental Content

Loading ...
Support Center